Erythropoietin improves anemia exercise tolerance and renal function and reduces B-type natriuretic peptide and hospitalization in patients with heart failure and anemia
- 31 December 2006
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 152 (6) , 1096.e9-1096.e15
- https://doi.org/10.1016/j.ahj.2006.08.005
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Epidemiology, treatment, and guidelines for the treatment of heart failure in EuropeEuropean Heart Journal Supplements, 2005
- Prevalence of anemia and effects on mortality in patients with heart failurePublished by Elsevier ,2005
- New Avenues of Exploration for ErythropoietinJAMA, 2005
- Anemia as a risk factor and therapeutic target in heart failureJournal of the American College of Cardiology, 2004
- Treating anemia early in renal failure patients slows the decline of renal function: A randomized controlled trialKidney International, 2004
- Impact of epoetin alfa on clinical end points in patients with chronic renal failure: A meta-analysisKidney International, 2004
- Prognostic value of cardiopulmonary exercise testing using percent achieved of predicted peak oxygen uptake for patients with ischemic and dilated cardiomyopathyJournal of the American College of Cardiology, 1996
- Pathogenesis of oedema in chronic severe anaemia: studies of body water and sodium, renal function, haemodynamic variables, and plasma hormones.Heart, 1993
- Validity of the Astrand-Ryhming nomogram for predicting maximal oxygen intake.British Journal of Sports Medicine, 1981
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976